Schlüter, A., Weller, P., Kanaan, O., Nel, I., Heusgen, L., Höing, B., . . . Brandau, S. (2018). CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer.
Citação norma ChicagoSchlüter, Anke, et al. "CD31 and VEGF Are Prognostic Biomarkers in Early-stage, but Not in Late-stage, Laryngeal Squamous Cell Carcinoma." BMC Cancer 2018.
MLA CitationSchlüter, Anke, et al. "CD31 and VEGF Are Prognostic Biomarkers in Early-stage, but Not in Late-stage, Laryngeal Squamous Cell Carcinoma." BMC Cancer 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.